NO880352D0 - Fremgangsmaate for fremstilling av 4-aryl-n-(2-(dialkylamino og heterocyklisk amino)alkyl)-1-piperazincarboxamider. - Google Patents

Fremgangsmaate for fremstilling av 4-aryl-n-(2-(dialkylamino og heterocyklisk amino)alkyl)-1-piperazincarboxamider.

Info

Publication number
NO880352D0
NO880352D0 NO880352A NO880352A NO880352D0 NO 880352 D0 NO880352 D0 NO 880352D0 NO 880352 A NO880352 A NO 880352A NO 880352 A NO880352 A NO 880352A NO 880352 D0 NO880352 D0 NO 880352D0
Authority
NO
Norway
Prior art keywords
dialcylamino
aryl
alkyl
procedure
preparation
Prior art date
Application number
NO880352A
Other languages
English (en)
Other versions
NO880352L (no
Inventor
David Allan Walsh
Albert Duncan Cale Jr
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of NO880352D0 publication Critical patent/NO880352D0/no
Publication of NO880352L publication Critical patent/NO880352L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
NO880352A 1987-01-28 1988-01-27 Fremgangsmaate for fremstilling av 4-aryl-n-(2-(dialkylamino og heterocyklisk amino)alkyl)-1-piperazincarboxamider. NO880352L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/007,592 US4960776A (en) 1987-01-28 1987-01-28 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides

Publications (2)

Publication Number Publication Date
NO880352D0 true NO880352D0 (no) 1988-01-27
NO880352L NO880352L (no) 1988-07-29

Family

ID=21727070

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880352A NO880352L (no) 1987-01-28 1988-01-27 Fremgangsmaate for fremstilling av 4-aryl-n-(2-(dialkylamino og heterocyklisk amino)alkyl)-1-piperazincarboxamider.

Country Status (10)

Country Link
US (1) US4960776A (no)
EP (1) EP0277725A3 (no)
JP (1) JPS63188670A (no)
AU (1) AU8067687A (no)
DK (1) DK39988A (no)
FI (1) FI880371A (no)
IL (1) IL84045A0 (no)
NO (1) NO880352L (no)
PT (1) PT86635B (no)
ZA (1) ZA877371B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3719612B2 (ja) * 1993-06-14 2005-11-24 塩野義製薬株式会社 ヘテロ環を含有する尿素誘導体
CA2184919C (en) * 1995-01-11 2000-03-14 Eui-Hwan Cho New piperazine derivatives and methods for the preparation thereof and compositions containing the same
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
WO2000063168A1 (en) * 1999-04-16 2000-10-26 Coelacanth Chemical Corporation Synthesis of azetidine derivatives
GB0421908D0 (en) 2004-10-01 2004-11-03 Angeletti P Ist Richerche Bio New uses
EP1989188B1 (en) 2006-02-28 2015-07-22 Dart Neuroscience (Cayman) Ltd Therapeutic piperazines as pde4 inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
FR2948370B1 (fr) 2009-07-27 2013-04-05 Sanofi Aventis Derives d'uree de tetrahydroquinoxaline, leur preparation et leur application en therapeutique
FR2948369B1 (fr) 2009-07-27 2013-04-12 Sanofi Aventis Derives d'uree de tetrahydroquinoxaline, leur preparation et leur application en therapeutique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2642255A (en) * 1947-12-10 1953-06-16 Weatherhead Co Packless valve
US3133067A (en) * 1959-01-30 1964-05-12 Sterling Drug Inc 1-monocarbocyclic aryl-4-thiocarbam-ylpiperazines and intermediates and processes therefor
NO154582C (no) * 1978-10-20 1986-11-05 Ferrosan Ab Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
JPS56127370A (en) * 1980-02-15 1981-10-06 Mitsui Toatsu Chem Inc Novel piperazine compound, its preparation and utilization
US4593102A (en) * 1984-04-10 1986-06-03 A. H. Robins Company, Inc. N-[(amino)alkyl]-1-pyrrolidine, 1-piperidine and 1-homopiperidinecarboxamides (and thiocarboxamides) with sulfur linked substitution in the 2, 3 or 4-position
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
US4594343A (en) * 1984-10-19 1986-06-10 Shanklin Jr James R 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles

Also Published As

Publication number Publication date
IL84045A0 (en) 1988-02-29
NO880352L (no) 1988-07-29
AU8067687A (en) 1988-08-04
FI880371A (fi) 1988-07-29
EP0277725A3 (en) 1988-08-31
JPS63188670A (ja) 1988-08-04
DK39988A (da) 1988-07-29
DK39988D0 (da) 1988-01-27
EP0277725A2 (en) 1988-08-10
PT86635A (pt) 1988-02-01
US4960776A (en) 1990-10-02
ZA877371B (en) 1988-04-11
FI880371A0 (fi) 1988-01-27
PT86635B (pt) 1992-01-31

Similar Documents

Publication Publication Date Title
NO905255L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler.
DK86688D0 (da) Maettede heterocycliske carboxamidderivater og fremgangsmaade til fremstilling heraf
DK147488D0 (da) Benzoxazolderivat samt fremgangsmaade til fremstilling deraf
NO902156D0 (no) Terapeutisk anvendbar oxadiazolforbindelse og fremgangsmaate for dens fremstilling.
NO862650D0 (no) Fremgangsmaate for fremstilling av heterocykliske substituert-fenoksyalkyl isoksazoler og -furaner.
DK186989A (da) Stabiliserede hoejumaettede fedtsyrer og derivater af saadanne syrer samt fremgangsmaade til fremstilling deraf
DK514688D0 (da) Heterocykliske peptidylforbindelser, fremgangsmaade til fremstilling deraf samt anvendelse af disse
NO905008D0 (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO880352D0 (no) Fremgangsmaate for fremstilling av 4-aryl-n-(2-(dialkylamino og heterocyklisk amino)alkyl)-1-piperazincarboxamider.
PT83451A (pt) Process for the preparation of derivatives of quinoline benzothiazole and analogous thereof
DK40487D0 (da) Heterocycliske lipoxygenaseinhibitorer og farmaceutisk acceptable salte deraf
DK397388D0 (da) Derivater af n-aminobutyl-n-phenylarylamider til terapeutisk anvendelse samt fremgangsmaade til fremstilling af saadanne derivater
DK437588D0 (da) Derivater af 2-((4-piperidinyl)methyl)-1,2,3,4-tetrahydroisoquinolin til terapeutisk anvendelse samt fremgangsmaade til fremstilling af saadanne derivater
DK381689A (da) Fremgangsmaade til konservering af ophthalmiske oploesninger og midler til anvendelse derved
NO862331D0 (no) Fremgangsmaate for surgjoering av silisiumholdige formasjoner.
DK84089D0 (da) Fremgangsmaade og mellemprodukter til fremstilling af quinolinderivater og farmaceutisk acceptable salte deraf
NO903386D0 (no) Fremgangsmaate for fremstilling av 4-(n-substituert amino)-2-butynyl-1-karbamater og -tiokarbamater og derivater derav.
NO882335D0 (no) Fremgangsmaate for fremstilling av 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener.
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
NO914577D0 (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser
NO912980D0 (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater
FI906162A (fi) Foerfarande foer framstaellning av 3-(n-metyl-n-alkyl)-amino-2-metoximetylenpropan-1-olderivat.
DK95588A (da) Fremgangsmaade til fremstilling af acetoacetylarylamider og -heteroarylamider af deaktiverede aromatiske forbindelser
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
NO972450D0 (no) Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav